萨科佩尼亚是瘤患者不良反应和死亡率的预后因素:系统性审查和元分析
Yujie Zhang1, Jingjing Zhang1, Yunfan Zhan1
1Clinical Research Center, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Journal of cachexia, sarcopenia and muscle
|November 12, 2024
概括
肉症是一种肌肉损失的情况,与接受放射或化疗的癌症患者的不良反应和死亡率增加有关. 这一系统性综述强调了类病对患者预后和治疗结果的重大影响.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 放射治疗和化疗疗法.
背景情况:
- 在接受放射和/或化疗的癌症患者中,肉类的预后影响尚不清楚.
- 萨科佩尼亚的特点是逐渐肌肉损失和衰弱,影响癌症患者的结果.
研究的目的:
- 调查萨科佩尼亚与不良影响以及死亡率之间的关联.
- 根据研究设计,瘤类型,肉症评估方法,治疗和位置分层发现.
主要方法:
- 在PubMed,Web of Science和Embase进行了全面的文献搜索.
- 包括至少100名癌症患者的队列研究,评估与治疗诱导的不良反应或存活率相关的肉症或肌肉质量.
主要成果:
- 涉及8966名患者的39项研究显示,肉症的综合患病率为42%.
- 在接受放射性和/或化疗的患者中,肉类显著增加了副作用的风险 (RR 1.44) 和降低了整体存活率 (HR 1.66).
- 患病率和风险因地理区域,瘤类型和评估方法而异.
结论:
- 萨科佩尼亚是接受放射和/或化疗的癌症患者不良反应和死亡的重要危险因素.
- 早期识别和治疗肉类可能会改善患者的预后和治疗结果.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K


